Research on the treatment of chronic lateral ankle instability combined with grade 1 inferior tibiofibular syndesmosis injury
The Journal of Foot and Ankle Surgery · 2026-01 · 65 (1) · 30.e1-30.e4
DOI: 10.1053/j.jfas.2025.09.005 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift The Journal of Foot and Ankle Surgery, 2026-01. Verfasst von Lijun Shi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Seventh Medical Center, People's Liberation Army General Hospital, Beijing 100700, China. Hauptthemen laut MEDLINE: Joint Instability, Ankle Injuries, Arthroscopy, Ankle Joint. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Chronic lateral ankle instability (CLAI) with concomitant Grade I inferior tibiofibular syndesmosis injury (ITSI) is frequently overlooked, leading to residual symptoms after isolated ligament repair. PURPOSE: To compare outcomes of arthroscopic modified Broström procedure (AMBP) alone versus AMBP plus syndesmotic fixation for CLAI with Grade I ITSI. STUDY DESIGN: Retrospective comparative cohort study. METHODS: From January 2021 to December 2022, 24 patients with chronic lateral ankle instability concomitant with Grade I inferior tibiofibular syndesmosis injury were assigned to either isolated AMBP (Group A, n = 13) or AMBP with elastic syndesmotic fixation (Group B, n = 11).Functional outcomes including the American Orthopedic Foot and Ankle Society score, Karlsson ankle joint function score, and pain visual analog scale score were assessed at final follow-up. Comparative analysis was conducted and the incidence of residual instability or recurrence was statistically analyzed. RESULTS: All patients in groups A and B were followed up until the last visit, with an average follow-up time of 25.7 ± 5 months (range: 18-37 months). There was a significant difference in functional scores between pre- and post-surgery for more than 1 year (P < 0.05). Arthroscopic modified Broström procedure combined with inferior tibiofibular syndesmosis fixation achieved higher scores compared with the two different treatment methods, and the difference was statistically significant (P < 0.05). CONCLUSION: When lateral ankle instability and Grade I inferior tibiofibular syndesmosis injury coexist, simultaneous repair of both injuries is more effective than isolated repair of the ATFL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedics, Seventh Medical Center, People's Liberation Army General Hospital, Beijing 100700, China.
- Department of Orthopedics, The 984th Hospital of the People's Liberation Army, Beijing 100094, China.
- Department of Orthopedics, Seventh Medical Center, People's Liberation Army General Hospital, Beijing 100700, China. Electronic address: zhangysmmu@163.com.
- Department of Orthopedics, Seventh Medical Center, People's Liberation Army General Hospital, Beijing 100700, China. Electronic address: huangyanlxq@126.com.
Zitieren
APA
Shi, L., Wu, J., Cao, R., Chen, D., Zhang, Y., & Huang, Y. (2026). Research on the treatment of chronic lateral ankle instability combined with grade 1 inferior tibiofibular syndesmosis injury. The Journal of Foot and Ankle Surgery, 65(1), 30.e1-30.e4. https://doi.org/10.1053/j.jfas.2025.09.005
Vancouver
Shi L, Wu J, Cao R, Chen D, Zhang Y, Huang Y. Research on the treatment of chronic lateral ankle instability combined with grade 1 inferior tibiofibular syndesmosis injury. The Journal of Foot and Ankle Surgery. 2026;65(1):30.e1-30.e4. doi:10.1053/j.jfas.2025.09.005
BibTeX
@article{Shi2026,
author = {Shi, Lijun and Wu, Jun and Cao, Ruihong and Chen, Dong and Zhang, Yang and Huang, Yan},
title = {Research on the treatment of chronic lateral ankle instability combined with grade 1 inferior tibiofibular syndesmosis injury},
journal = {The Journal of Foot and Ankle Surgery},
year = {2026},
volume = {65},
number = {1},
pages = {30.e1--30.e4},
doi = {10.1053/j.jfas.2025.09.005}
}
EUVIMED